The death and re-birth of endoAVF systems, part one: “The only thing that stifled it was withdrawal from the market”

A global all-star cast of experts discuss the re-emergence of endoAVF, the percutaneous creation of arteriovenous fistulas (AVFs) for dialysis access, as the Ellipsys vascular access system (Ellipsys Medical) returns to the US market following Medtronic’s discontinuation of the device last year. In a roundtable discussion at CX 2026, host Nick Inston (University Hospital Birmingham NHS Foundation Trust, Birmingham, UK) talks through developments with Alexandros Mallios (Hôpital Paris Saint-Joseph, Paris, France), Kate Steiner (University Hospitals Sussex NHS Foundation Trust, Brighton, UK) and Bart Dolmatch (Palo Alto Medical Foundation, Palo Alto, USA). They touch on faltering uptake of the approach, economics around the procedure and the patient journey after endoAVF creation.